An in vivo defect model for testing cell-based tissue engineering strategies for early osteoarthritis

Authors :: Franke, D
Pattappa, G
Koch, M
Weber, J
Johnstone, B
Docheva, D
Zellner, J
Angele, P
Source :: Deutscher Kongress für Orthopädie und Unfallchirurgie (DKOU 2019); 20191022-20191025; Berlin; DOCAB59-940 /20191022/
Publication Year :: 2019
Publisher :: German Medical Science GMS Publishing House, 2019.
Abstract: Objectives: Osteoarthritis (OA) is a joint disease involving progressive and degenerative changes to cartilage encompassing a variety of etiologies including post-traumatic incident or aging. It can be treated at its early stages through cell-based tissue engineering therapies using Mesenchymal Stem[for full text, please go to the a.m. URL]<br />Deutscher Kongress für Orthopädie und Unfallchirurgie (DKOU 2019)

Subjects :: mesenchymal stem cells
ddc: 610
tissue engineering
in vivo model
610 Medical sciences
Medicine
early osteoarthritis
cartilage

Language :: English
Database :: OpenAIRE
Journal :: Deutscher Kongress für Orthopädie und Unfallchirurgie (DKOU 2019); 20191022-20191025; Berlin; DOCAB59-940 /20191022/
Accession number :: edsair.doi.dedup.....6ce1ca90a09bac3bdd2771069ff9cfa5
Full Text :: https://doi.org/10.3205/19dkou558

Full Text Access

Tools